Science and Research

ABCA3-related interstitial lung disease beyond infancy

BACKGROUND: The majority of patients with childhood interstitial lung disease (chILD) caused by pathogenic variants in ATP binding cassette subfamily A member 3 (ABCA3) develop severe respiratory insufficiency within their first year of life and succumb to disease if not lung transplanted. This register-based cohort study reviews patients with ABCA3 lung disease who survived beyond the age of 1 year. METHOD: Over a 21-year period, patients diagnosed as chILD due to ABCA3 deficiency were identified from the Kids Lung Register database. 44 patients survived beyond the first year of life and their long-term clinical course, oxygen supplementation and pulmonary function were reviewed. Chest CT and histopathology were scored blindly. RESULTS: At the end of the observation period, median age was 6.3 years (IQR: 2.8-11.7) and 36/44 (82%) were still alive without transplantation. Patients who had never received supplemental oxygen therapy survived longer than those persistently required oxygen supplementation (9.7 (95% CI 6.7 to 27.7) vs 3.0 years (95% CI 1.5 to 5.0), p=0.0126). Interstitial lung disease was clearly progressive over time based on lung function (forced vital capacity % predicted absolute loss -1.1% /year) and on chest CT (increasing cystic lesions in those with repetitive imaging). Lung histology pattern were variable (chronic pneumonitis of infancy, non-specific interstitial pneumonia, and desquamative interstitial pneumonia). In 37/44 subjects, the ABCA3 sequence variants were missense variants, small insertions or deletions with in-silico tools predicting some residual ABCA3 transporter function. CONCLUSION: The natural history of ABCA3-related interstitial lung disease progresses during childhood and adolescence. Disease-modifying treatments are desirable to delay such disease course.

  • Li, Y.
  • Seidl, E.
  • Knoflach, K.
  • Gothe, F.
  • Forstner, M. E.
  • Michel, K.
  • Pawlita, I.
  • Gesenhues, F.
  • Sattler, F.
  • Yang, X.
  • Kroener, C.
  • Reu-Hofer, S.
  • Ley-Zaporozhan, J.
  • Kammer, B.
  • Krüger-Stollfuß, I.
  • Dinkel, J.
  • Carlens, J.
  • Wetzke, M.
  • Moreno-Galdó, A.
  • Torrent-Vernetta, A.
  • Lange, J.
  • Krenke, K.
  • Rumman, N.
  • Mayell, S.
  • Sismanlar, T.
  • Aslan, A.
  • Regamey, N.
  • Proesmans, M.
  • Stehling, F.
  • Naehrlich, L.
  • Ayse, K.
  • Becker, S.
  • Koerner-Rettberg, C.
  • Plattner, E.
  • Manali, E. D.
  • Papiris, S. A.
  • Campo, I.
  • Kappler, M.
  • Schwerk, N.
  • Griese, M.

Keywords

  • Abca3
  • paediatric interstitial lung disease
  • rare lung diseases
Publication details
DOI: 10.1136/thorax-2022-219434
Journal: Thorax
Work Type: Original
Location: CPC-M, BREATH
Disease Area: DPLD
Partner / Member: KUM, MHH
Access-Number: 36808083

DZL Engagements

chevron-down